Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization

International Journal of Cardiology Congenital Heart Disease

卷:4

Pier Paolo Bassareo¹  Giovanni Di Salvo²  Michael A. Gatzoulis³  Jolanda Sabatino⁴  Giuseppe Calcaterra⁴  Maria Pia Calabrò⁵  Paolo Guccione⁶  Lilia Oreto⁷  Ilaria Cazzoli⁸ 

[1] Corresponding author.;

[2] Division of Cardiology, “Magna Graecia” University, Catanzaro, Italy;

[3] Department of Human Pathology of Adulthood and Childhood - Pediatric Cardiology Unit, University of Messina, Messina, Italy;

[4] Division of Paediatric Cardiology, Department of Women's and Children's Health, University of Padua, Padua, Italy;

[5] Mediterranean Pediatric Cardiology Center, Bambino Gesù Pediatric Hospital, Taormina, Messina, Italy;

[6] Pediatric Cardiology and Cardiac Surgery Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy;

[7] Post Graduate Medical School, University of Palermo, Palermo, Italy;

[8] University College of Dublin Mater Misericordiae University Hospital (National Adult Congenital Disease Service) and Our Lady's Children's Hospital Crumlin, Ireland;

关键词: ACHD;    COVID-19;    Vaccine;    Risk factors;   

DOI  :  

来源: DOAJ

【 摘 要 】

Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exposure and clinical risk of patients with adult congenital heart disease (ACHD) and to propose a risk profile schema for those patients to be incorporated into vaccine distribution decisions.

【 授权许可】

Unknown